Results 271 to 280 of about 378,238 (343)

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

open access: yesCancer Science, EarlyView.
In the global, phase 3 KEYNOTE‐522 study of high‐risk early‐stage triple‐negative breast cancer (TNBC), neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab improved efficacy outcomes versus neoadjuvant chemotherapy alone. In this analysis of Japanese participants from KEYNOTE‐522, neoadjuvant pembrolizumab plus chemotherapy ...
Masato Takahashi   +16 more
wiley   +1 more source

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series

open access: yes
British Journal of Haematology, EarlyView.
Ekaterina Balaian   +6 more
wiley   +1 more source

An updated look into reactive oxygen species and cyclophosphamide-induced ovarian damage. [PDF]

open access: yesJ Ovarian Res
Camp OG   +5 more
europepmc   +1 more source

Detection of vascular amyloid deposits in a bone marrow aspirate

open access: yes
British Journal of Haematology, EarlyView.
Konstantinos Liapis   +3 more
wiley   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

open access: yesJAMA Oncol
Shadman M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy